Elan, in conjunction with Wyeth, is proud to be a Gold sponsor of the 10th International Conference on Alzheimer's Disease and Related Disorders (ICAD), in Madrid on July 15-20, 2006. The conference promises to be a unique and exciting opportunity for scientists and clinicians from around the world to come together to discuss recent clinical, diagnostic and research findings in the field of Alzheimer's disease and related disorders.

Elan is deeply committed to developing new and innovative therapies to address the significant unmet medical need represented by the ever-growing population of patients suffering from Alzheimer's disease.

We are presenting a satellite symposium at ICAD, “Current Progress on the Beta-Amyloid Peptide as a Therapeutic Target in Alzheimer's Disease,” featuring leading AD researchers from throughout the field. In addition, several Elan posters and presentations showcase our current research efforts in Alzheimer's disease.

Elan considers conferences such as ICAD to be important forums that encourage open dialogue and exchange of information within the scientific community. We look forward to sharing and learning about new and improved approaches for treating this devastating disease that may provide new hope for patients, families and caregivers.

Sincerely,

Lars Ekman
EVP and President, Global R&D